U.S. pharmaceutical companies are stepping up their campaign for higher drug prices in Europe, in some cases threatening to ...
AMD researchers argue that, while algorithms like the Ozaki scheme merit investigation, they're still not ready for prime ...
Society for Science (the Society) announced the top 300 scholars in the Regeneron Science Talent Search 2026, the nation’s ...
Orbis Investment Management released its Q4 2025 investor letter for “Orbis SICAV International Equity Fund”. The Strategy reported a positive year in 2025, with returns driven more by stock-specific ...
TAE Life Sciences is developing a next-generation boron neutron capture therapy for cancer. After recently introducing Alphabeam, a compact and affordable accelerator-based neutron system suitable for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results